Concepedia

Alice S. Mims

AS

80

Publications

5.8K

Citations

36

H-Index

2012

Active since

Affiliations

The Ohio State University(Current)

Memorial Sloan Kettering Cancer Center

Emory University

Dana-Farber Cancer Institute

The University of Texas MD Anderson Cancer Center

Alice S. Mims is an author at The Ohio State University specializing in medicine, oncology, and cancer research.

ORCID

Top concepts

Publications per year

2012–2025

80

Publications

80

Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML

Courtney D. DiNardo, Eytan M. Stein, Stéphane de Botton et al. · New England Journal of Medicine · 2018 · 1.4K citations · Full text

Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology

Martin S. Tallman, Eunice S. Wang, Jessica K. Altman et al. · Journal of the National Comprehensive Cancer Network · 2019 · 418 citations

, , +15

Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia

Gail J. Roboz, Courtney D. DiNardo, Eytan M. Stein et al. · Blood · 2019 · 363 citations · Full text

NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021

Daniel A. Pollyea, Dale L. Bixby, Alexander E. Perl et al. · Journal of the National Comprehensive Cancer Network · 2021 · 314 citations · Full text

, , +13

Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study

Eytan M. Stein, Courtney D. DiNardo, Amir T. Fathi et al. · Blood · 2020 · 228 citations · Full text

Rows per page

1–5 of 80